Samuel J Reich - Net Worth and Insider Trading

Samuel J Reich Net Worth

The estimated net worth of Samuel J Reich is at least $26 Million dollars as of 2024-05-12. Samuel J Reich is the CEO and CFO, 10% Owner of Blue Calypso Inc and owns about 3,048,825 shares of Blue Calypso Inc (BCYP) stock worth over $26 Million. Samuel J Reich is also the Executive Chairman of SAB Biotherapeutics Inc and owns about 76,670 shares of SAB Biotherapeutics Inc (SABS) stock worth over $307,447. Details can be seen in Samuel J Reich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Samuel J Reich has not made any transactions after 2023-11-29 and currently still holds the listed stock(s).

Transaction Summary of Samuel J Reich

To

Samuel J Reich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel J Reich owns 2 companies in total, including OPKO Health Inc (OPK) , and SAB Biotherapeutics Inc (SABS) .

Click here to see the complete history of Samuel J Reich’s form 4 insider trades.

Insider Ownership Summary of Samuel J Reich

Ticker Comapny Transaction Date Type of Owner
OPK OPKO Health Inc 2007-03-29 Executive VP
SABS SAB Biotherapeutics Inc 2023-11-29 director & Executive Chairman

Samuel J Reich Latest Holdings Summary

Samuel J Reich currently owns a total of 2 stocks. Among these stocks, Samuel J Reich owns 3,048,825 shares of Blue Calypso Inc (BCYP) as of October 14, 2021, with a value of $26 Million and a weighting of 98.82%. Samuel J Reich also owns 76,670 shares of SAB Biotherapeutics Inc (SABS) as of November 29, 2023, with a value of $307,447 and a weighting of 1.18%.

Latest Holdings of Samuel J Reich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCYP Blue Calypso Inc 2021-10-14 3,048,825 8.44 25,732,083
SABS SAB Biotherapeutics Inc 2023-11-29 76,670 4.01 307,447

Holding Weightings of Samuel J Reich


Samuel J Reich Form 4 Trading Tracker

According to the SEC Form 4 filings, Samuel J Reich has made a total of 2 transactions in Blue Calypso Inc (BCYP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Blue Calypso Inc is the acquisition of 1,000 shares on October 14, 2021, which cost Samuel J Reich around $10,110.

According to the SEC Form 4 filings, Samuel J Reich has made a total of 1 transactions in SAB Biotherapeutics Inc (SABS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SAB Biotherapeutics Inc is the acquisition of 1,100 shares on November 29, 2023, which cost Samuel J Reich around $9,790.

Insider Trading History of Samuel J Reich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samuel J Reich Trading Performance

GuruFocus tracks the stock performance after each of Samuel J Reich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel J Reich is -48.74%. GuruFocus also compares Samuel J Reich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel J Reich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samuel J Reich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samuel J Reich

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -20.98
Relative Return to S&P 500(%) -25.8

Samuel J Reich Ownership Network

Ownership Network List of Samuel J Reich

No Data

Ownership Network Relation of Samuel J Reich


Samuel J Reich Owned Company Details

What does OPKO Health Inc do?

Who are the key executives at OPKO Health Inc?

Samuel J Reich is the Executive VP of OPKO Health Inc. Other key executives at OPKO Health Inc include 10 percent owner Frost Phillip Md Et Al , director & Chief Innovation Officer Gary J. Nabel , and director & Vice Chairman and President Elias A. Zerhouni .

OPKO Health Inc (OPK) Insider Trades Summary

Over the past 18 months, Samuel J Reich made no insider transaction in OPKO Health Inc (OPK). Other recent insider transactions involving OPKO Health Inc (OPK) include a net purchase of 12,436,531 shares made by Frost Phillip Md Et Al , a net purchase of 400,010 shares made by Hsiao Jane Ph D , and a net purchase of 676,429 shares made by Gary J. Nabel .

In summary, during the past 3 months, insiders sold 0 shares of OPKO Health Inc (OPK) in total and bought 3,600,000 shares, with a net purchase of 3,600,000 shares. During the past 18 months, 0 shares of OPKO Health Inc (OPK) were sold and 14,188,270 shares were bought by its insiders, resulting in a net purchase of 14,188,270 shares.

OPKO Health Inc (OPK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OPKO Health Inc Insider Transactions

No Available Data

Samuel J Reich Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel J Reich. You might contact Samuel J Reich via mailing address: Acuity Pharmaceuticals Inc, 3701 Market Street, Philadelphia Pa 19104.

Discussions on Samuel J Reich

No discussions yet.